NCT00490529 2020-01-13
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
Stanford University
Phase 2 Completed
Clinical Trials
7 trialsNCT00880581 2017-03-14
A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas
Stanford University
Phase 2 Completed
NCT00085189 2014-05-22
Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma
University of Southern California
Phase 2 Completed
NCT00321815 2010-12-23
Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer
Pfizer
Phase 2 Completed
NCT00043368 2009-03-12
PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
Pfizer
Phase 2 Completed
NCT00070629 2009-02-10
CPG 7909 Injection in Non-Small Cell Lung Cancer
Pfizer
Phase 2 Completed
NCT00070642 2009-02-10
CPG 7909 Injection in Melanoma
Pfizer
Phase 2 Completed